← FDA Drug Approvals (Drugs@FDA)
NORETHINDRONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2013-08-01
Drug application
- FDA Application #
ANDA202260- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NORETHINDRONE
- Generic name
- Norethindrone
- Active ingredients
- NORETHINDRONE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Discontinued
- Sponsor
- AMNEAL PHARMS
- First approval
- 2013-08-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown